A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
Article Details
Authors (16)
Youmei Xiao
School of Pharmaceutical Sciences (Shenzhen)
Zhuoying He
School of Pharmaceutical Sciences (Shenzhen)
Wanqiong Li
Danhong Chen
School of Pharmaceutical Sciences (Shenzhen)
Xiaoshuang Niu
School of Pharmaceutical Sciences (Shenzhen)
Xin Yang
Wenxuan Zeng
School of Pharmaceutical Sciences (Shenzhen)
Mengfan Wang
School of Pharmaceutical Sciences (Shenzhen)
Yuzhen Qian
Ye Su
School of Pharmaceutical Sciences (Shenzhen)
Feiyu Luo
School of Pharmaceutical Sciences (Shenzhen)
Guanyu Chen
Laboratory of Advanced Materials, Shanghai Key Lab of Molecular Catalysis and Innovative Materials, Department of Materials Science, Academy for Engineering & Technology
Juan Liu
Xinghua Sui
Xiuman Zhou
Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital
Yanfeng Gao
School of Pharmaceutical Sciences (Shenzhen)